An Open, Non-comparative Study to Evaluate the Efficacy and Safety of AUGMENTIN 1gm (875mg Amoxicillin/125mg Clavulanic Acid) po q 12 Hours in the Treatment of Uncomplicated Skin and Soft Tissue Infections in Pakistan

NCT00343135 Phase 4 COMPLETED

Study to evaluate the effects of AUGMENTIN 1gm in the treatment of Skin and Soft tissue infections

Details

Lead sponsor	GlaxoSmithKline
Phase	Phase 4
Status	COMPLETED
Enrolment	195
Start date	2004-12
Completion	2005-03

Conditions

• Skin Diseases, Infectious
• Infection, Soft Tissue

Interventions

• amoxicillin/clavulanate potassium 1gm

Primary outcomes

• Clinical response at 10 - 14 days post therapy — 10 - 14 days

Countries

Pakistan